Sign in

CIK 0001566044

  • Non-accelerated filer
  • Smaller reporting company

Yarrow Bioscience, Inc.

Sign in to watch
Ticker
YARW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
453757789
Phone
+1 203-433-7577
Business address
470 JAMES STREET, SUITE 007, NEW HAVEN, CT, 06513
Former names
VYNE Therapeutics Inc., Menlo Therapeutics Inc., Menlo Therapeutics, Inc., Tigercat Pharma, Inc.
  1. 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 94 shares (to pay taxes)
  2. 4 Shares withheld for taxes CHIEF SCIENTIFIC OFFICER gave up 157 shares (to pay taxes)
  3. 4 Shares withheld for taxes CHIEF LEGAL OFFICER AND GC gave up 161 shares (to pay taxes)
  4. 4 Shares withheld for taxes PRESIDENT AND CEO gave up 1,004 shares (to pay taxes)
  5. 4 Shares withheld for taxes Chief Financial Officer gave up 93 shares (to pay taxes)
  6. 4 Shares withheld for taxes Chief Scientific Officer gave up 157 shares (to pay taxes)
  7. 4 Shares withheld for taxes Chief Legal Officer and GC gave up 161 shares (to pay taxes)
  8. 4 Shares withheld for taxes President and CEO gave up 1,004 shares (to pay taxes)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 3 Insider Initial Statement of Ownership
  16. 4 Grant or award Chief Financial Officer acquired 62,500 shares (grant or award)
  17. 4 Grant or award Chief Scientific Officer acquired 62,500 shares (grant or award)
  18. 4 Grant or award Chief Legal Officer and GC acquired 62,500 shares (grant or award)
  19. 4 Grant or award President and CEO acquired 225,000 shares (grant or award)
  20. 4 Derivatives Options or other derivatives

Page 5 of 17 · 330 filings